Health Trials

Relapsed/Refractory Lymphoma

2

Review clinical trials related to Relapsed/Refractory Lymphoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy

This study is a single-center, open-label clinical trial of single-dose of CAR T-cells in subjects with relapsed/refractory hematologic malignancy.

Participants needed: 9
Trial details
Phase: Early Phase 1Age: 18-70Biological sex: AllType: InterventionalSponsor: Affiliated Hospital of Nantong UniversityUpdated: Jan 3, 2025Locations: 1
Eligibility criteria

Voluntarily participate in the clinical study. The individual or the legal guard... [+32]

CNS-3 disease is defined as detectable tumor cells in the cerebrospinal fluid (C... [+33]

Read more
Status: Recruiting

Safety and Efficacy of Anti-CD20/CD30 CAR-T Cells in Subjects with Relapsed/Refractory Lymphoma

This study is an exploratory clinical trial of a single-center, open-label, single-dose treatment of anti-CD20/CD30-CAR-T cells in subjects with relapsed/refractory lymphoma.

Participants needed: 9
Trial details
Phase: Early Phase 1Age: 14-70Biological sex: AllType: InterventionalSponsor: Shanghai First Song Biotechnology Co., LTDUpdated: Sep 19, 2024Locations: 1
Eligibility criteria

Voluntarily participate in the clinical study. The individual or the legal guard... [+34]

MRI of the brain shows evidence of central nervous system lymphoma; active prima... [+30]

Read more